While monotherapies already slightly delayed leukemia development in mice transplanted with FLT3-ITD+ MV4–11, co-inhibition of lactate import and ETC complex II significantly further delayed leukemia onset compared to the vehicle group (Fig. 5n). The gene discussed is FLT3; the disease is leukemia.